Drug prohibition law

Drug prohibition law is prohibition-based law by which governments prohibit, except under licence, the production, supply, and possession of many, but not all, substances which are recognized as drugs, and which corresponds to international treaty commitments in the Single Convention on Narcotic Drugs 1961, the Convention on Psychotropic Substances 1971, and the United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances 1988.

When produced, supplied or possessed under licence, otherwise prohibited drugs are known as controlled drugs. The aforementioned legislation is the cultural institution and social fact that de facto divides world drug trade as illegal vs legal, according to geopolitical issues. The United Nations has its own drug control programme, as part of the United Nations Office on Drugs and Crime (UNODC), which was formerly called the United Nations Office for Drug Control and Crime Prevention (ODCCP), and the Commission on Narcotic Drugs is the central drug policy-making body within the United Nations system.

Schedule 3

Schedule 3/Schedule III may refer to:

See also

Controlled Substances Act

The Controlled Substances Act (CSA) is the statute prescribing federal U.S. drug policy under which the manufacture, importation, possession, use and distribution of certain substances is regulated. It was passed by the 91st United States Congress as Title II of the Comprehensive Drug Abuse Prevention and Control Act of 1970 and signed into law by President Richard Nixon. The Act also served as the national implementing legislation for the Single Convention on Narcotic Drugs.

The legislation created five Schedules (classifications), with varying qualifications for a substance to be included in each. Two federal agencies, the Drug Enforcement Administration and the Food and Drug Administration, determine which substances are added to or removed from the various schedules, although the statute passed by Congress created the initial listing. Congress has sometimes scheduled other substances through legislation such as the Hillory J. Farias and Samantha Reid Date-Rape Prevention Act of 2000, which placed gamma hydroxybutyrate in Schedule I. Classification decisions are required to be made on criteria including potential for abuse (an undefined term), currently accepted medical use in treatment in the United States, and international treaties.